IND/IDE

IND/IDE Terms

Definitions

Expand all

  • Adverse drug experience

  • Annual reports

  • Biological product

  • Botanical drug

  • Case Report Form (CRF)

  • Clinical monitoring

  • Contract Research Organization (CRO)

  • Device

  • Dietary supplements

  • Drug

  • Effective date

  • Fatal Adverse Drug Experiences

  • FDA

  • FD&C Act

  • Good Clinical Practice (GCP)

  • IAP

  • IDE

  • IDE exemption

  • IND

  • IND exemption

  • Investigational new drug

  • Investigator

  • Institutional Review Board (IRB)

  • Life-threatening adverse drug experiences

  • Nonsignificant risk devices

  • Protocol

  • Serious Adverse Event (SAE)

  • Sponsor

  • Sponsor-Investigator

  • Subject

  • Significant risk devices

  • Unexpected adverse drug experience

Contact Us


Human Research Protection Program
(ML0567)
University Hall, Suite 300
51 Goodman Drive
PO Box 210567
Cincinnati, OH 45221-0567
General Inquiries:
513-558-5259
irb@ucmail.uc.edu

Click here to identify the person dedicated to serving your research group

 

Angela Braggs-Brown, RAC, CIP, MA
Director
513-558-3005
angela.braggs-brown@uc.edu

Kareemah Mills, CIP
Assistant Director
513-558-3576
kareemah.mills@uc.edu

Claudia Norman, CIP
Education and Outreach Specialist
513-558-5784
claudia.norman@uc.edu

Human Protection Administrators
Laura Goins
513-558-0479
laura.goins@uc.edu

Martina Harmon, MS
513-558-1881
martina.harmon@uc.edu

Tara Knipp, CIP
513-558-3731
tara.knipp@uc.edu

Christa Preston, CIP
513-558-2087
christa.preston@uc.edu

Deborah Quinones-Stewart
513-558-6915
deborah.quinones-stewart@uc.edu

Quality Assurance Auditors
Jackie Glass, CCRP
513-558-0453
jacklyn.glass@uc.edu


StrokeNet CIRB

Susan Roll, RN, BSN, CCRP
CIRB Liaison
513-558-6061
susan.roll@uc.edu

Jo Ann Behrle
Human Protection Administrator
513-558-5273
joann.behrle@uc.edu

Keeley Lynch
CIRB Coordinator
513-558-5209
keeley.lynch@uc.edu